New Therapeutics in HER2-Positive Advanced Breast Cancer: Towards a Change in Clinical Practices?

Over the last few decades, improved knowledge of oncogenic activation mechanisms of HER2 protein has led to the development of HER2 targeted therapies that are currently commonly used in HER2-positive advanced breast cancer, such as trastuzumab, lapatinib, pertuzumab, and ado-trastuzumab emtansine....

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Cancers (Basel)
Main Authors: Mezni, Essia, Vicier, Cécile, Guerin, Mathilde, Sabatier, Renaud, Bertucci, François, Gonçalves, Anthony
Format: Artigo
Sprog:Inglês
Udgivet: MDPI 2020
Fag:
Review
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7352740/
https://ncbi.nlm.nih.gov/pubmed/32545895
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12061573
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker